Edition:
United States

Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

73.95EUR
16 Aug 2019
Change (% chg)

€1.45 (+2.00%)
Prev Close
€72.50
Open
€72.80
Day's High
€73.95
Day's Low
€72.55
Volume
64,641
Avg. Vol
102,188
52-wk High
€82.60
52-wk Low
€53.10

About

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial... (more)

Overall

Beta: 0.36
Market Cap(Mil.): €8,348.02
Shares Outstanding(Mil.): 118.36
Dividend: 0.33
Yield (%): 0.47

Financials

  BIOX.PA Industry Sector
P/E (TTM): 42.79 31.72 32.67
EPS (TTM): 1.65 -- --
ROI: 8.88 14.11 14.48
ROE: 12.39 16.67 15.78

Turkey's BIM 2018 net profit jumps 45 percent to 1.25 bln lira

ISTANBUL, March 7 Turkish discount retailer BIM posted a net profit of 1.25 billion lira ($230 million) in 2018, up 45 percent from a year earlier, it said late on Wednesday.

Mar 06 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates